These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 19586585)
21. New neurotoxins on the horizon. Freeman SR; Cohen JL Aesthet Surg J; 2008; 28(3):325-30. PubMed ID: 19083544 [TBL] [Abstract][Full Text] [Related]
22. The Potential Role of Botulinum Toxin in Improving Superficial Cutaneous Scarring: A Review. Dhawan A; Dhawan S; Vitarella D J Drugs Dermatol; 2018 Sep; 17(9):956-958. PubMed ID: 30235381 [TBL] [Abstract][Full Text] [Related]
23. Therapeutic use of botulinum toxins: background and history. Setler PE Clin J Pain; 2002; 18(6 Suppl):S119-24. PubMed ID: 12569958 [TBL] [Abstract][Full Text] [Related]
24. Botulinum neurotoxin: the ugly duckling. Koussoulakos S Eur Neurol; 2009; 61(6):331-42. PubMed ID: 19365125 [TBL] [Abstract][Full Text] [Related]
25. Antipruritic Effects of Botulinum Neurotoxins. Gazerani P Toxins (Basel); 2018 Mar; 10(4):. PubMed ID: 29596343 [TBL] [Abstract][Full Text] [Related]
26. Botulinum Toxin for Central Neuropathic Pain. Park J; Chung ME Toxins (Basel); 2018 Jun; 10(6):. PubMed ID: 29857568 [TBL] [Abstract][Full Text] [Related]
27. Botulinum neurotoxin A in ophthalmology. Bentley C Ophthalmic Physiol Opt; 1996 Mar; 16 Suppl 1():S9-14. PubMed ID: 8796194 [No Abstract] [Full Text] [Related]
28. Botulinum neurotoxin in muscle overactivity. Esquenazi A J Head Trauma Rehabil; 2005; 20(6):563-7. PubMed ID: 16304491 [No Abstract] [Full Text] [Related]
29. Botulinum toxins in pain management. Royal MA Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):805-20. PubMed ID: 14580039 [TBL] [Abstract][Full Text] [Related]
30. Botulinum Toxin for Neuropathic Pain: A Review of the Literature. Oh HM; Chung ME Toxins (Basel); 2015 Aug; 7(8):3127-54. PubMed ID: 26287242 [TBL] [Abstract][Full Text] [Related]
31. Introduction to the Luvisetto S Toxins (Basel); 2023 Sep; 15(9):. PubMed ID: 37755966 [TBL] [Abstract][Full Text] [Related]
33. The analgesic effects of botulinum neurotoxin by modulating pain-related receptors; A literature review. Hosseindoost S; Askari Rad M; Inanloo SH; Rahimi M; Dehghan S; Orandi A; Dehpour AR; Majedi H Mol Pain; 2024; 20():17448069241275099. PubMed ID: 39093638 [TBL] [Abstract][Full Text] [Related]
34. Novel Botulinum Neurotoxins: Exploring Underneath the Iceberg Tip. Tehran DA; Pirazzini M Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29748471 [TBL] [Abstract][Full Text] [Related]
35. Human T-cell responses to botulinum neurotoxin. Responses in vitro of lymphocytes from patients with cervical dystonia and/or other movement disorders treated with BoNT/A or BoNT/B. Oshima M; Deitiker PR; Jankovic J; Duane DD; Aoki KR; Atassi MZ J Neuroimmunol; 2011 Dec; 240-241():121-8. PubMed ID: 22079193 [TBL] [Abstract][Full Text] [Related]
36. Gastroparesis Concurrent with Adult Cystic Fibrosis; Are They Related? Mandaliya R; Hadjiliadis D; Cohen S Am J Med; 2016 May; 129(5):e21-2. PubMed ID: 26836386 [No Abstract] [Full Text] [Related]
37. Targeted secretion inhibitors-innovative protein therapeutics. Keith F; John C Toxins (Basel); 2010 Dec; 2(12):2795-815. PubMed ID: 22069575 [TBL] [Abstract][Full Text] [Related]
38. The Use of Botulinum Toxin in Pain Management: Basic Science and Clinical Applications. Hehr JD; Schoenbrunner AR; Janis JE Plast Reconstr Surg; 2020 Mar; 145(3):629e-636e. PubMed ID: 32097334 [TBL] [Abstract][Full Text] [Related]
39. Novel therapeutic uses and formulations of botulinum neurotoxins: a patent review (2012 - 2014). Kane CD; Nuss JE; Bavari S Expert Opin Ther Pat; 2015 Jun; 25(6):675-90. PubMed ID: 25842964 [TBL] [Abstract][Full Text] [Related]
40. Botulinum Toxin: Does it have a Place in the Management of Depression? Rudorfer MV CNS Drugs; 2018 Feb; 32(2):97-100. PubMed ID: 29498020 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]